Eli Lilly and Co(LLY)
357.78
Change: -2.43 (▼ -0.68%)
As of Tue 12/20/2022 06:04 PM% Of Value
Growth
Value Per Share
:
:
:
556.06
15.40
36.3300 (as of 19/12/2022)
Fundamentals Data
| Open | 357.81 | Dividend | 1062 |
| Close Price | 357.78 | DivYield | 2.59 % |
| High | 359.7 | Growth | 3.7 B |
| Low | 354.6101 | Growth% | 15.40 |
| P/e | 39.238 | Volume | 2.6 M |
| P/b | 2.32 | Market Capital | 342.9 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 354.79 (as of 20/12/2022) | 50 Days Moving Average Percentage | 1.4509041415516 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 22.8 B | 24.5 B | 22.3 B | 24.5 B | 28.3 B |
| Cap Spending | -1.0 B | -1.2 B | -1.0 B | -1.3 B | -1.3 B |
| Operating Expenses | 14.6 B | 14.3 B | 12.3 B | 11.8 B | 14.8 B |
| Operating Cash Flow | 2.1 B | 3.7 B | 5.2 B | 7.2 B | 6.1 B |
| Free Cash Flow | 4.5 B | 4.3 B | 3.8 B | 5.1 B | 5.9 B |
| Free Cash Flow Per Share | 4.353 | 4.201 | 4.084 | 5.632 | 6.561 |
| Total liabilities | 13.6 B | 12.7 B | 15.8 B | 16.5 B | 16.8 B |
| Total cash | 6.5 B | 7.9 B | 2.3 B | 3.6 B | 3.8 B |
| ROE% | -0.015 | 0.264 | 2.958 | 1.404 | 0.742 |
| Outstanding Shares | 1.0 B | 1.0 B | 956.3 M | 958.4 M | 952.3 M |
| P/E | -416.284 | 39.126 | 16.191 | 31.948 | 40.66 |
| P/S | 3.715 | 5.15 | 6.035 | 8.063 | 8.014 |
| Revenue USD | 22.8 B | 24.5 B | 22.3 B | 24.5 B | 28.3 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|